Daily tracking of hereditary angioedema burden
Part of Genetic & congenital, Heart & circulation, Immune system & allergy, Skin clinical trials.
This study uses a smartphone app to track how hereditary angioedema affects your daily life over 8 weeks. It aims to better understand the real-world burden of the condition and may help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 1 or type 2 hereditary angioedema (HAE).
- You are 18 years old or older.
- You own and can use a personal smartphone that works with the m-Path app (Android or iPhone).
- You are willing to use the app and answer daily questions for 8 weeks.
- You do not have other types of angioedema or severe mental health issues that would prevent you from completing the questionnaires.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is an extension trial of an oral medicine (PHA-022121) for treating acute attacks in people with hereditary angioedema (HAE), especially HAE type III (HAE-nC1INH). It checks whether continuing this oral treatment can safely help manage attacks after you’ve taken it before.
This study looks for genetic changes that may explain hereditary angioedema (HAE) and how C1 inhibitor (C1INH) works. Your participation may help researchers better understand what causes symptoms and who is affected.
This study tests a new medicine called ADX-324 to see if it can prevent HAE attacks in adults with type I or II HAE. If you've had attacks recently and are willing to pause your current prevention medication, this trial may be an option.
This study tests whether a smartphone app called Medidux helps you manage your symptoms and discharge from the hospital if you came in with coughing, back pain, or belly discomfort. You'll use the app to report how you're feeling, and the care team can check in with you after you leave.
This study is testing whether a blood pressure monitoring system called Aktiia can help people become aware of high blood pressure early and predict heart risks. It involves using a smartphone and a wrist bracelet (or just the phone's camera) to take blood pressure readings.
This study checks if a blood test measuring C1-inhibitor function can help diagnose hereditary angioedema (HAE), a rare condition that causes painful swelling episodes. If you or a close family member have had swelling without rash or itching that lasts 1-5 days and doesn't get better with allergy meds, this trial may be for you.
Hear when a new Hereditary Angioedema With C1 Esterase Inhibitor Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.